Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
11.95
-0.47 (-3.78%)
At close: Aug 1, 2025, 4:00 PM
12.00
+0.05 (0.42%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Crescent Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Cash & Equivalents
34.77
Cash & Short-Term Investments
34.77
Prepaid Expenses
0.04
Total Current Assets
34.8
Long-Term Deferred Charges
0.8
Other Long-Term Assets
0.01
Total Assets
35.62
Accounts Payable
0.11
Accrued Expenses
9.45
Other Current Liabilities
0.06
Total Current Liabilities
9.61
Long-Term Debt
37.48
Total Liabilities
47.1
Common Stock
0
Additional Paid-In Capital
2.39
Retained Earnings
-17.87
Total Common Equity
-15.48
Shareholders' Equity
-11.48
Total Liabilities & Equity
35.62
Total Debt
37.48
Net Cash (Debt)
-2.72
Net Cash Per Share
-0.51
Filing Date Shares Outstanding
7.05
Total Common Shares Outstanding
7.05
Working Capital
25.19
Book Value Per Share
-2.20
Tangible Book Value
-15.48
Tangible Book Value Per Share
-2.20
Updated Jun 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.